DSpace BSMU (Chernivtsy, Ukraine): Browsing DSpace

Browsing by Author Sydorchuk, I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 1 to 7 of 7

Issue Date	Title	Author(s)
2022	Aldosterone synthase CYP11B2 (-344C/T) gene polymorphism influences risk of chronic kidney disease in patients with arterial hypertension	Dzhuryak, V.; Sydorchuk, A.; Voroniuk, K.; Sydorchuk, L.; Repchuk, Yu.; Semianiv, M.; Sydorchuk, R.; Sydorchuk, I.; Iftoda, O.
2022	Dependence of metabolic disorders on aldosterone synthase CYP11B2 (-344C/T) gene polymorphism in hypertensive patients	Dzhuryak, V.; Sydorchuk, L.; Repchuk, Yu.; Semianiv, M.; Voroniuk, K.; Sydorchuk, I.; Iftoda, O.; Sydorchuk, R.
2014	Endothelial dysfunction and system inflammatory response markers in hypertensive patients with acute myocardial infarction depending on polymorphism of ACE (I/D) and eNOS (894G>T)	Sydorchuk, A.; Sydorchuk, R.; Sydorchuk, L.; Amosova, K.M.; Sydorchuk, I.; Ursuliak, U.
2022	Endothelial nitric oxide synthase gene polymorphism (894G>T, 786T>C) contribute to hypertension risk and lipids profile disorders	Dzhuryak, V.; Sydorchuk, A.; Sydorchuk, L.; Sydorchuk, R.; Sydorchuk, I.; Iftoda, O.
2013	Lipopolysaccharide induces neovascularization and immunosuppression, and must be considered as therapentic target	Sydorchuk, L.; Fomin, P.; Sydorchuk, R.; Sydorchuk, I.; Plehutsa, O.; Sydorchuk, A.
2010	Pharmacogenetically determined treatment' influence Left Ventricular Mass Index (LVMI) in relation to polymorphisms of ACE, AGTR1, eNOS, PPAR-G2, ADRB1 genes in essential hypertensive (EAH) patients	Sydorchuk, L.; Amosova, K.M.; Sydorchuk, R.; Ursuliak, U.; Sydorchuk, I.
2013	Why targeting vascular endothelial growth factor is not sufficiently effective?	Plehutsa, O.; Sydorchuk, A.; Fomin, P.; Sydorchuk, I.; Sydorchuk, R.; Sydorchuk, L.; Levites, S.; Vinohradskyy, A.

Showing results 1 to 7 of 7